OPTIMIZERx is trading at $8.50, up +5.72% in pre-market on September 3, 2026, following the company’s September 2 announcement that former Johnson & Johnson executive Troy Sarich joined its advisory board.
- Sarich brings nearly 30 years of healthcare, pharmaceutical commercialization, data, analytics, and AI experience.
- The appointment may strengthen commercialization and technology strategy.
- No earnings or guidance announcement was identified.